X4 Pharmaceuticals, Inc. appointed Kelly Gold as a Class II director and Audit Committee member, effective July 1, 2026. This appointment increased the Board of Directors from five to six members. X4 Pharmaceuticals, Inc. is a biopharmaceutical company.
